Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

TORONTO and LOS ANGELES, May 10, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today released a Marketing Code designed to responsibly move the emerging cannabis industry forward. Cronos Group believes that those below the legal age of consumption should not be targeted in an adult-use cannabis market. Cronos Group recognizes there is a clear need for standards. That's why the Company proactively created its own and is sharing its principles publicly as a resource for the industry and policymakers.

Cronos Group Launches Marketing Code to Drive Responsibility Within the Cannabis Industry

Aurora Cannabis

Canopy Growth

Mastercard

Visa

British Columbia Investment Management slashed positions in Canopy Growth, Aurora Cannabis, and Cronos Group in the first quarter, and bought up Mastercard and Visa stock.

Giant Pension Sold Marijuana Stocks Canopy, Aurora, and Cronos. Two Stocks It Bought.

Although Cronos Group Inc (NASDAQ: CRON) refers to itself as an iconic global brand, many investors might call it a big disappointment. Currently trading down over 70% from its Feb. 4, 2019 high of $25, Cronos has failed to garner any excitement over its brands or its partnerships and its fourth-quarter financials were another massive miss.

Did Cronos Group's 'Happy Dance' Brand Cheer Traders Up?

Cronos Group, Inc. (CRON) CEO Kurt Schmidt on Q1 2021 Results - Earnings Call Transcript

Investors are focused on the future, not the past.

Why Cronos Group Shares Rose Despite Worse-Than-Expected Q1 Results

Marijuana stocks rose on Friday, even as Cronos Group reported first-quarter results that missed expectations. The post Cronos Misses But Marijuana Stocks Rise As Alabama Eyes Medical Pot appeared first on Investor's Business Daily.

Cronos Misses But Marijuana Stocks Rise As Alabama Eyes Medical Pot

Cronos (CRON) delivered earnings and revenue surprises of -50.00% and -25.02%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Cronos Group (CRON) Reports Q1 Loss, Misses Revenue Estimates

Cronos Group Inc (NASDAQ: CRON) reported a Q1 adjusted EBITDA loss of $37.07 million, marginally up from $37.05 million reported a year ago. This slight increase in losses was primarily driven by the rise in sales and marketing costs due to brand development in the U.S. segment and an increase in R&D costs.

Cronos Q1 Earnings Impacted By COVID-19 Related Restrictions

Cronos Group Inc.'s U.S.-listed shares slid 4.2% in premarket trading Friday, after the Canadian cannabis company posted weaker-than-expected earnings for the first quarter. Cronos said it had a net loss of C$161.6 million ($132.7 million), or 44 cents a share, in the quarter, after income of C$75.7 million, or 20 cents a share, in the year-earlier period.

Cronos shares slide premarket after earnings fall short of estimates

Receives processing license for the commercial production and sale of cannabinoids using biosynthesis

Cronos Group Reports 2021 First Quarter Results

Ocugen, Inc.

Schnitzer Steel Industries Inc

Let us take a look at three small biotech companies, RDUS, CRON and OCGN, which are gearing up for their earnings release.

Drug/Biotech Stock Q1 Earnings on May 7: RDUS, CRON & OCGN

Curaleaf Holdings, Inc.

GrowGeneration Corp

Green Thumb Industries Inc.

HEXO Corp

Innovative Industrial Properties

SNDL Inc.

Tilray Brands

Returns in weed stocks have been all over the place, and largely based on geography. Here's where 10 of the biggest names stand now.

The 10 Hottest Weed Stocks On the Market For May

Are Canadian Marijuana Stocks Positioned For Future Gains? The post How Do You Invest In Marijuana Stocks? 2 Canadian Pot Stocks To Watch In May appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

How Do You Invest In Marijuana Stocks? 2 Canadian Pot Stocks To Watch In May

Cronos (CRON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Cronos Group (CRON) Q1 Earnings Expected to Decline

C3.ai

Enphase Energy

Li Auto Inc.

MP Materials

Palo Alto Networks

Splunk

Tuscan Holdings

Zomedica

Are you looking for the top stocks of 2021? InvestorPlace pros are betting on these 11 bullseye investments in red-hot themes.

Top Stocks 2021: 11 Bullseye Stock Picks for Your Must-Buy List

How to approach and invest in the cannabis industry the Foolish way.

Investing in Cannabis Stocks? Check Out This Podcast.

Aphria

OrganiGram Holdings Inc.

Looking for cannabis exposure? These seven weed stocks based in Canada could provide some explosive growth to portfolios over time.

7 Marijuana Stocks to Buy As Canada's Consumption Continues to Rise

It would be fair to say that cannabis stocks received three positive indicators over the past six months.

BofA Analysts Say These Are the 2 Weed Stocks to Buy

We continue to be perplexed by the elevated valuation of Cronos; its 32x EV/Sales is difficult to be justified based on fundamentals. It reported $47M revenue and $147M negative EBITDA for 2020 which we view as the weakest among the top 10 Canadian LPs.

Cronos: The Most Confusing Cannabis Stock

As New York's recreational cannabis industry shapes up, a group of individuals will play a big role in shaping the market's future. The Empire State legalized cannabis on March 31. More regulations and details are expected in the coming months as members are appointed to the Office of Cannabis Management and Cannabis Control Board — the regulatory bodies responsible for the industry.

See the power players shaping the future of New York's $7 billion cannabis industry

These cannabis producers already have a presence south of the border.

4 Canadian Cannabis Companies Poised to Profit from U.S. Legalization

Will it be déjà vu for investors, or is marijuana reform really on its way?

This Upcoming Catalyst Could Send Marijuana Stocks Soaring

2 Marijuana Stocks To Watch Before May Arrives The post Are These The Best Canadian Marijuana Stocks To Buy Before May? 2 To Watch This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are These The Best Canadian Marijuana Stocks To Buy Before May? 2 To Watch This Week

Amplify Alternative Harvest ETF

Altria

Constellation Brands

Marijuana stocks have been hot and cold for years. Coming off a strong stretch, investors hope the group -- including these seven marijuana stocks -- can find its footing and go higher.

7 Marijuana Stocks To Buy As Usage Moves Mainstream

TORONTO, April 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 First Quarter Earnings Conference Call on Friday, May 7, 2021 at 8:30 a.m. EDT. Cronos Group's senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

Cronos Group Inc. to Hold 2021 First Quarter Earnings Conference Call on May 7, 2021

News for Cronos Group Stock (CRON)